M&A Deal Summary |
|
|---|---|
| Date | 2021-05-04 |
| Target | Kuur Therapeutics |
| Sector | Life Science |
| Buyer(s) | Athenex |
| Deal Type | Add-on Acquisition |
| Deal Value | 185M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2003 |
| Sector | Life Science |
| Employees | 652 |
| Revenue | 120M USD (2021) |
Athenex is a global biopharmaceutical company dedicated to discovery, development, and commercialization of novel therapies for the treatment of cancer. Athenex was founded in 2003 and is based in Buffalo, New york.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| Country: United Kingdom M&A | 1 of 1 |
| Year: 2021 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-09-09 |
QuaDPharma
New York, New York, United States QuaDPharma specializing in pharmaceutical manufacturing, analytical, and support services to the pharmaceutical and biotech industries. |
Buy | - |